Cirrhosis other imaging findings: Difference between revisions
(→Tc-99m) |
No edit summary |
||
| Line 4: | Line 4: | ||
{{CMG}}; {{AE}} {{ADI}} | {{CMG}}; {{AE}} {{ADI}} | ||
==Overview== | ==Overview== | ||
[[Tc-99m]] labeled sulfur can be used in [[nuclear imaging]] to obtain an indication of hepatic function. CTA is used to asses the drainage of the liver, when assessing a patient for [[liver transplant]]. | |||
==Other Imaging Findings== | ==Other Imaging Findings== | ||
===Nuclear Imaging=== | ===Nuclear Imaging=== | ||
Revision as of 14:41, 7 September 2012
|
Cirrhosis Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case studies |
|
Cirrhosis other imaging findings On the Web |
|
American Roentgen Ray Society Images of Cirrhosis other imaging findings |
|
Risk calculators and risk factors for Cirrhosis other imaging findings |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Aditya Govindavarjhulla, M.B.B.S. [2]
Overview
Tc-99m labeled sulfur can be used in nuclear imaging to obtain an indication of hepatic function. CTA is used to asses the drainage of the liver, when assessing a patient for liver transplant.
Other Imaging Findings
Nuclear Imaging
Tc-99m
Tc-99m labeled sulfur used for functional imaging techniques provides some indication of hepatic function. The labeled colloidal compound is taken up by reticuloepithelial cells, and the colloidal shift in other organs (bone marrow,spleen) containing reticuloepithelial cells provides evidence of portal hypertension. [1]
Angiography
Angiography is currently used for assisting in the placement of catheters for CTA. The angiographic findings of hepatic perfusion remains essential in transplant assessment, given the variability of the liver's drainage from its arterial and venous supplies.
References